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G-protein-coupled receptors (GPCRs) respond to external stimuli
by activating heterotrimeric G proteins inside the cell. There is
increasing evidence that many GPCRs exist as dimers or higher
oligomers, but the biochemical nature of such dimers and what
roles they have, if any, in signal transduction remains unclear. We
conducted a comprehensive study of dimerization of the 5HT2c
serotonin receptor using disulphide-trapping experiments. We
found a dimer interface between transmembrane (TM) helices
IV and V that is markedly sensitive to the state of receptor
activation. This dimer seems to be quasisymmetrical in interfacial
geometry and asymmetrical in its association with its cognate Ga
protein. We also found a second interface at TM I helices, which
is insensitive to the state of activation.
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INTRODUCTION
G-protein-coupled receptors (GPCRs) mediate intracellular responses
to a wide variety of external stimuli (Pierce et al, 2002). These
receptors have in common a seven-helical transmembrane (7TM)
domain and the ability to activate heterotrimeric G proteins in
response to ligand stimulation, presumably through a conserved
mechanism (Luttrell, 2006).
Despite the biomedical importance of GPCRs, there is much
uncertainty about how they function at a molecular level.
Landmark crystal structures of bovine rhodopsin (Palczewski
et al, 2000; Li et al, 2004; Salom et al, 2006) provide a powerful
framework, but they also leave important questions unanswered.
For example, the nature of rearrangements by which a receptor
in the inactive state shifts on stimulation to one able to activate
G proteins remains open for debate. Similarly, there seems to be
no consensus on the nature and physiological relevance of
GPCR oligomerization.
GPCRs were initially thought to exist and function only as
monomers (reviewed by Chabre & le Maire, 2005). However,
compelling results from the g-aminobutyric acid type B (GABAB)
receptor—a family C GPCR—first indicated that these receptors
might function as dimers (Marshall et al, 1999). Since then,
evidence for rhodopsin-like GPCRs (family A) being dimers
or higher-order oligomers has increased quickly. This has
come from various GPCRs in diverse experiments including
fluorescence resonance energy transfer (FRET) and bioluminescence
resonance energy transfer measurements, chemical crosslinking,
co-immunoprecipitation, atomic force microscopy, neutron scat-
tering and modelling (reviewed by Javitch, 2004; Park et al, 2004;
Terrillon & Bouvier, 2004). Nevertheless, reports that strictly
monomeric receptors are able to activate G proteins (Chabre & le
Maire, 2005; White et al, 2007; Whorton et al, 2007) cast doubts
on the dimer being the true or only functional unit.
Our studies focus on rat 5HT2c (Julius et al, 1988), the subtype 2c
receptor for the neurotransmitter 5-hydroxytryptamine (5HT;
serotonin). 5HT2 receptors couple to Gaq to activate the
phospholipase C/b signalling pathway, and they have a rich
pharmacology, including well-characterized agonists, partial
agonists, antagonists and inverse agonists (Barnes & Sharp,
1999). Our ongoing efforts to determine the high-resolution
structure of 5HT2c have led us to investigate the physiologically
relevant state of this receptor. Dimeric associations of 5HT2c
(Herrick-Davis et al, 2004) are postulated to have functional
importance (Herrick-Davis et al, 2005), but the detergent-
extracted receptor behaves as a monomer (F.M. & W.A.H.,
unpublished data). Thus, we sought to identify interfaces of self-
association for 5HT2c on cells, both to investigate their roles in
receptor function and to aid us in engineering physiologically
meaningful receptor species for structural analysis.
We used a cysteine crosslinking approach (Guo et al, 2003,
2005; Klco et al, 2003; Kota et al, 2006) that was aimed at
providing a systematic study of contacts between 5HT2c receptor
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363molecules as expressed on the plasma membrane of living cells.
Two distinct dimerization interfaces emerged: one at TM I, the
other between TMs IV and V. The TM I interface does not vary with
activation state, whereas the IV/V interface shows clear sensitivity
to the character of ligands bound to 5HT2c. The IV/V interface
seems to be asymmetric, and most noticeably so in the active state.
It seems that activated 5HT2c is a conformational heterodimer.
RESULTS
Design of cysteine mutants
Cysteine replacement of an appropriately disposed pair of residues
at an oligomeric interface is expected to generate a disulphide
bridge. Therefore, we devised a disulphide-trapping plan that
would be both comprehensive and also limited in scope for
feasibility. We reasoned that residues near the extracellular
surface would be susceptible to oxidation for disulphide formation
and that surface-exposed residues would be the most likely
interfacial contacts. Thus, by homology with rhodopsin
(Palczewski et al, 2000; Li et al, 2004), we found 30 5HT2c sites
with appropriate surface exposure within 8A ˚ of the putative
external cell surface, including one naturally occupied by
cysteine. This set, including 3–5 sites on each helix, was later
supplemented by neighbours of the reactive residues to bring the
total cysteine sites to 46 (Fig 1).
Mapping of disulphide accessible dimer interfaces
We cloned all of the mutants into a vector for expression in
mammalian cells (Mancia et al, 2004), and tested each one
individually (45 transfections) by using transient transfection into
human embryonic kidney 293 (HEK293) cells and as pairs by
cotransfection. Cell-surface expression was verified by immuno-
cytochemistry (supplementary Fig S1 online). Pairs were chosen so
that each single mutant would reside in a different helix and with
expected heights along the helices within 5A ˚ from each other.
Pairs were tested from all contiguous helices, as well as from TMs
I/III, I/VI, II/IV, II/VII, III/V, IV/VI, IV/VII and V/VII. A total of 323
different pairs were cotransfected. To maximize the likelihood of
disulphide bond formation, for these initial rounds of experiments,
transfected cells were exposed to the hyperoxidizing environment
of Cu-phenanthroline (CuP) before collection. Dimer formation was
assessed by western blot analysis of detergent-solubilized and
deglycosylated (supplementary Fig S2 online) cellular lysates or of
enriched preparations following immunoprecipitation with 5HT2c
antibodies (Mancia et al, 2007; supplementary Fig S3 online). These
experiments led to the identification of 30 possible candidates.
The definition of dimer interfaces was refined under a more
stringent protocol. The 30 transfections that showed interactions
following CuP-mediated oxidation were repeated using only
natural air oxidation, keeping all other experimental procedures
the same. Transfection of individual mutants revealed only a
single interface at TM I, most prominently marked by N55C and
W56C (Fig 2A). Cotransfected pairs of mutants showed a clear
interface between TMs IV and V (Fig 2B). The residues involved
were carefully mapped along these helices (data not shown), and
the crucial pairs responsible for this interaction were identified
as Ile193 on TM IV matched with Pro213 and Asn214 on TM V
(Fig 2B). Crosslinked yields were close to 50% as expected from
the trapping of AB ‘heterodimers’ away from non-crosslinkable AA
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Fig 1 |Schematic plan for mutational design. A cartoon of the rhodopsin-based model of 5HT2c is viewed from above and within the membrane plane
(left), and the indicated portion of the 7TM bundle is unwrapped and segments are viewed as vertical cylinders (right). Residues selected for mutation
to cysteine are indicated in numbered circles centred at Cb positions. Those meeting the criteria for surface exposure are circled in blue, except for a
wild-type cysteine circled in green and those selected as neighbours of initial positive response that are circled in red. The scale reports z-displacement (A ˚)
from the water–lipid interface. 5HT2c, subtype 2c receptor for 5-hydroxytryptamine; TM, transmembrane.
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364(e.g. I193C) and BB (e.g. P213C) ‘homodimers’, in which each
dimer species was equally probable. These ratios remained
unchanged for IV/V pairs even when forced by CuP oxidation,
whereas for the TM I mutants higher CuP concentrations could
force complete dimer capture (data not shown). The air-oxidized
TM I and IV/V crosslinkings seem to reflect authentic dimerization,
as captured dimer fractions are only weakly sensitive to 100-fold
dilution of transfected DNA (supplementary Fig S4 online;
supplementary Table S1 online).
Ligand sensitivity at dimer interfaces
To assess the ligand sensitivity of the two interfaces, cells
transfected with either the single mutants from TM I or the pairs
of mutants from TMs IV and V were cultured in the presence of
10mM agonist (serotonin), antagonist (mesulergine), inverse
agonist (ketanserin) or no ligand. Dialysed serum was used to
minimize the amount of naturally present serotonin. The TM I
interface seemed insensitive to the activation state of 5HT2c
(Fig 3A); crosslinkings of N55C and W56C mutants were the same
for cells cultured with the different ligands and then subjected to
various means for cysteine crosslinking (supplementary Fig S5
online; supplementary Table S2 online). By contrast, the TM IV/V
interface showed marked ligand sensitivity (Fig 3B). In particular,
crosslinking for the I193C/P213C pair of mutant variants seemed
to follow the activation state of the receptor. The pair shows no
crosslinking for the inactive state of inverse-agonist-treated cells,
but the amount of dimer increases progressively through an
antagonist-bound state and the absence of ligand, and on to a fully
active state with serotonin (Fig 3C, supplementary Table S2
online). Both IV/V disulphides form in the absence of ligand, but
only the I193C/N214C bridge is consistent with the inactive,
ketanserin state, whereas the I193C/P213C bridge prevails for the
active, serotonin state. These data are indicative of a substantial
conformational change at the TM IV/V interface during 5HT2c
receptor activation.
Evidence for dimer asymmetry
Our earliest bacterial expressions had already provided evidence
of asymmetry in 5HT2c dimers as half of the protein from
membranes was cleaved (Fig 4A). More recently, we found that
receptors expressed in glycosylation-deficient HEK293 cells
(Mancia et al, 2007) were also half cleaved, removing 15
amino-terminal residues and a glycosylation site (Fig 4B). We
consistently observed approximately 50:50 cleavage patterns,
indicating in each case that just one protomer of a dimer was
susceptible to proteolysis. Receptors from each source bind to
ligands and conformation-sensitive antibodies.
Although a IV/V dimer interface between rhodopsin-like
receptors could be twofold symmetrical as viewed into the
membrane (Fig 1), it might also be quasisymmetrical. Then, the
environment of helix IV on one protomer interacting with V0 on
the other would differ from that of V with IV0. Asymmetry could
arise because of protomers having distinct conformations or
because of rigid-body rotations. To investigate the symmetry of the
TM IV/V dimer interface, we generated two double-modified
receptors: one bearing I193C-P213C mutations and another
I193C-N214C mutations. We transfected these double mutants
using our standard protocol and compared them with the
cotransfected single mutants. We expected that an intrinsically
symmetrical TM IV/V interface would be enforced in such double
mutants, and that a distinctly asymmetrical dimer would form a
disulphide linkage with whichever alternative cysteine pair was in
contact. Either way, the dimer:monomer ratio should then
increase in our crosslinking gels. However, what we should
expect from a quasisymmetric interface that partly occluded the
alternative site was unclear.
Intriguingly, the experiment showed a rather complex picture
(Fig 5A). When cells were maintained in the presence of serotonin,
dimers prevailed for the I193C–N214C pairing, whereas expres-
sion levels were greatly reduced for the I193C–P213C pairing.
Analogous double-serine mutations were fully tolerated (supple-
mentary Fig S6 online). For inverse-agonist-treated cells, the
crosslinking pattern did not vary between the cotransfected single
mutants and the transfected double mutants. We interpreted the
agonist-state results as indicative of a quasisymmetrical receptor in
which both 193/214 crosslinks can form comfortably, but where
formation of dual 193/213 crosslinks destabilizes the receptor. The
contrasting ketanserin results are somewhat puzzling, but perhaps
the dimer is more labile in the inactive state than when activated.
Re-equilibration of cotransfected species might then lead to the
same crosslinking results as from the double mutants.
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Fig 2 |Identification of dimer interfaces. (A) Dimerization along TM I.
Western blots compare transfected 5HT2c mutants as oxidized by CuP
(left) and by air (right). WT is wild-type 5HT2c. Monomer (M) and
dimer (D) bands are indicated by arrows. (B) Dimerization at the TM
IV/V interface. Pairs that showed dimerization under CuP-promoted
oxidation were re-screened using air oxidation. Western blots for
ten of these are shown, highlighting the IV/V interaction. 5HT2c,
subtype 2c receptor for 5-hydroxytryptamine; CuP, Cu-phenanthroline;
TM, transmembrane.
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365As the double-cysteine experiments showed the greatest sensi-
tivity for the I193C/P213C pairing in serotonin (Fig 5A), we studied
activation using carboxy-terminal fusions of the cognate Gaq protein
to these receptors (Milligan et al, 2004). We cotransfected mutant
receptors having Ga fused alternatively to one or the other cysteine
mutant in the pair. We expected that the location of the G protein
should not matter for a symmetrical homodimer, but that one
alternative might be preferred for a conformationally asymmetrical
dimer. We observed marked differences for the alternatives (Fig 5B,
supplementary Fig S7 online). I193C/P213C–Gaq forms well and, in
5HT, it favours dimerization when compared with I193C/P213C,
whereas productive expression of I193C–Gaq is much reduced in
the I193C–Gaq/P213C pairing. Both Gaq fusions express robustly
when alone (Fig 5B). Expression patterns also differed for the
alternative 193/213 fusions in ketanserin (Fig 5B, right), but there
was much less asymmetry for the 193/214 pair (supplementary
Fig S7 online). The results are consistent with Ga stabilization of the
activated receptor in an apparently asymmetrical dimer.
DISCUSSION
Our experimental design aimed to provide a systematical and
comprehensive survey of potential sites of intermolecular contact
for 5HT2c expressed in mammalian cells. We tested 46 cysteine
residues, distributed along all seven TM segments (Fig 1), in more
than 350 individual or pairwise experiments covering all possible
combinations. Although several candidate contacts were detected
with CuP-promoted oxidation, only a few survived in natural
air oxidation, which selects for proximal sites appropriately
oriented for disulphide formation. Two independent interfaces
emerged from these studies: one along TM I, and the other
between TMs IV and V (Fig 2).
Our data indicate that 5HT2c exists as a dimer on the plasma
membrane of living cells. This is not surprising given other data on
GPCR dimerization (Javitch, 2004) and FRET evidence for 5HT2c
being a dimer (Herrick-Davis et al, 2004). Moreover, our finding of
an interface between IV and V is roughly compatible with
crosslinking, mostly CuP- or HgCl2-promoted, of the dopamine
receptor D2R (Guo et al, 2003) and of rhodopsin (Kota et al, 2006),
as well as with models of rhodopsin dimers (Fotiadis et al,2 0 0 4 ) .I n
5HT2c, this interface is clearly sensitive to activation state (Fig 3B),
as was also observed for D2R (Guo et al, 2005). Conformational
rearrangements are such that Ile193 of TM IV and Pro213 of TM V
come closer together on serotonin activation from the basal state
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Fig 3 |Ligand sensitivity at dimer interfaces. Cells were incubated with no ligand, serotonin, mesulergine or ketanserin. (A) TM I. Western blots
compare transfected 5HT2c mutants N55C and W56C from cells maintained in the four ligand environments. (B) TM IV/V. Western blots compare
5HT2c mutants transfected individually and as pairs (I193C/P213C and I193C/N214C), with wild-type (WT) and empty vector (Mock) controls.
(C) Quantification from replicated TM IV/V experiments. 5HT, serotonin; 5HT2c, subtype 2c receptor for 5-hydroxytryptamine; Ket, ketanserin;
Mes, mesulergine; NoL, no ligand; TM, transmembrane.
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Fig 4 |Half-of-the-sites proteolysis of 5HT2c in membranes. (A) Receptor
expressed in bacteria as a maltose-binding protein (MBP) fusion and
probed with anti-MBP. Length of the MBP-2cDC half is consistent with loop
V–VI cleavage. (B) Western blot of receptor induced to express in human
embryonic kidney 293 GntI  cells. Amino-terminal sequencing identified
products of signal-peptide (33IVTDy) and adventitious (48QFPDy)
proteolysis. 5HT2c, subtype 2c receptor for 5-hydroxytryptamine.
Serotonin receptor dimers
F. Mancia et al
EMBO reports VOL 9 | NO 4 | 2008 &2008EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
scientificreport
366and move out of crosslinking range on inactivation by the inverse
agonist ketanserin. By contrast, crosslinking between I193C and
N214C is comparable in all these states.
From crosslinking observations on double mutants (Fig 5A),
we conclude that the IV/V interface is only quasisymmetrical, that
is, symmetrical enough to allow dual I193C–N214C disulphide
bonds, but asymmetrical enough not to tolerate dual I193C–
P213C bonds. Thus, at least in the active state, it seems that
5HT2c is not a homodimer, but a conformational heterodimer.
This hypothesis is strengthened by data on receptor–Ga fusions;
receptor stability and the extent of dimerization differs according
to whether Ga is fused to the receptor mutated on TM IV or to the
one on TM V (Fig 5B). Moreover, 5HT2c in membranes is
susceptible to half-of-the-sites proteolysis (Fig 4). These data are in
line with emerging hypotheses of a distinct role for each protomer
in the GPCR dimer during activation (Damian et al, 2006;
Vilardaga et al, 2008).
The TM I interface is insensitive to activation state (Fig 3A) and
presumably symmetrical. However, as TMs IV and V are opposite
from TM I, existence of both IV/V and I/I interfaces suggests that
higher-order oligomers should form. Oligomeric assemblages of
rhodopsin in rod outer segments, seen by atomic force microscopy,
have been modelled in just this manner (Fotiadis et al,2 0 0 4 ) ,a n d
such clustering has also been indicated for C5a following
disulphide-trapping experiments (Klco et al, 2003). Postsynaptic
clustering of 5HT2c and other neurotransmitter GPCRs is also
plausible; however, we have yet to see proof of such oligomerization.
Cotransfection of one receptor bearing both N55C (TM I) and
I193C (TM IV), with another having both N55C and P213C
(TM V), gave no evidence of higher-order oligomers under our
experimental conditions, which was possibly inconclusive
owing to low abundances of diverse large species (supplementary
Fig S8 online). Thus, the physiological role of TM I-mediated
dimerization is still unclear.
Speculation
Our structural image of the ligand-sensitive 5HT2c dimer is based on
homology with rhodopsin. Keeping the monomer conformation
intact, we built a dimer that has a slightly asymmetrical IV/V interface
(Fig 6) to be consistent with our observations. As 11-cis retinal
rhodopsin is in the inactivated state, this image is probably akin to
5HT2c with the inverse agonist ketanserin. Pro213 (TM V) is not
accessible to Ile193 (TM IV) in this conformation, and its observed
accessibility in the presence of the agonist serotonin requires a
conformational change. Details of this state remain to be seen, but we
expect a conformational heterodimer that is asymmetrical with respect
to its interaction with Ga. This molecular snapshot of membrane-
bound 5HT2c dimers in action might also capture other GPCRs.
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Fig 5 |Conformational asymmetry in the 5HT2c dimer. (A) Two singles compared with one double. Western blots compare transfectants from cells
maintained in serotonin (5HT) and ketanserin (Ket), in which transfectants include single mutants, pairs of single mutants (I193C/P213C, I193C/N214C)
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into cells, alone or in cotransfections, and maintained either with 5HT or Ket. Controls are labelled as in Fig 3B. Receptor species are labelled according
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Selection of sites for cysteine mutagenesis. Sites in 5HT2c were
chosen so that the homologous residue in the rhodopsin structure
(Protein Data Bank code 1GZM) would be exposed on the
receptor surface, to make cysteine crosslinking feasible, and to be
near the cell surface to facilitate oxidation for disulphide
formation. Residues with more than 40% surface area exposed
and lying within the region from approximately 6A ˚ outside to
approximately 8A ˚ below the extracellular surface were selected
for modification to cysteine in 5HT2c (Fig 1). Other sites were
selected later on the basis of positive responses of their neighbours.
Generation of cysteine mutants and of Ga fusions. Mutations
were introduced into rat 5HT2c complementary DNA following
standard protocols. Receptor–Ga fusions were generated by in-
frame cloning of a GGGS linker segment in place of the 5HT2c
stop codon and ahead of codon Thr2 of human Gaq. The resulting
DNA constructs were cloned into pFM1.2 (Mancia et al, 2004) for
expression in mammalian cells.
Cell culture and transfections. HEK293 cells were maintained as
described previously (Mancia et al, 2007). Transfections were
performed in a six-well format with 2mg total of DNA, using
Lipofectamine and Plus Reagent (Invitrogen, Carlsbad, CA, USA).
Dialysed serum was used in the cell growth medium for
experiments involving 5HT2c ligands. Ligands were added to
the transfected cells at 10mM concentration and maintained until
collection, 48h later.
Cysteine crosslinking. For air-promoted oxidation, cells were
washed in PBS and plated with PBS-based cell dissociation
solution (Enzyme Free; Chemicon, Billerica, MA, USA). For CuP-
promoted oxidation, cells were washed with PBS, and incubated
for 30min at B221C in PBS with 200mM CuSO4 and 640mM
1,10-phenanthroline (Sigma, St Louis, MO, USA). The reaction
was quenched by washing the cells with PBS and harvesting them
with Enzyme Free containing 10mM N-ethylmaleimide. Ligands,
when required, were present at all times.
Immunoprecipitation and immunoblotting. Cell pellets were
solubilized in dodecylmaltoside/cholesteryl-hemisuccinate, cleared
of insoluble material, and deglycosylated with PNGaseF (New
England Biolabs, Ipswich, MA, USA). Immunoprecipitations were
performed as described previously using 5HT2c monoclonal
antibody 5H8 (Mancia et al, 2007). Nonreducing gels were loaded
with 20mg of crude lysate or the immunoprecipitate from one well
of the six-well dish. Blots were probed with a monoclonal antibody
against an epitope tag for crude lysates and those on immuno-
precipitated samples were probed with 2HT2c polyclonal antibodies.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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